National Health Investors/$NHI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About National Health Investors
National Health Investors Inc is a housing and medical facility REIT. The company operates through two reportable segments, i.e., Real Estate Investments and Senior Housing Operating Portfolio (SHOP). The Real Estate Investments segment, which generates maximum revenue, consists of real estate investments and leases, mortgages, and other notes receivables in independent living facilities, assisted living facilities, entrance fee communities, senior living campuses, skilled nursing facilities, and a hospital. The SHOP segment is comprised of two ventures that own the operations of independent living facilities. The company's revenues are derived in the form of rental income, mortgage and other notes receivable interest income, and resident fees and services.
Ticker
$NHI
Sector
Primary listing
NYSE
Industry
Health Care REITs
Headquarters
Employees
30
ISIN
US63633D1046
Website
NHI Metrics
BasicAdvanced
$3.3B
22.44
$3.16
0.81
$3.60
5.08%
Price and volume
Market cap
$3.3B
Beta
0.81
52-week high
$84.32
52-week low
$65.13
Average daily volume
322K
Dividend rate
$3.60
Financial strength
Current ratio
0.619
Quick ratio
0.58
Long term debt to equity
64.882
Total debt to equity
87.429
Dividend payout ratio (TTM)
112.29%
Interest coverage (TTM)
3.23%
Profitability
EBITDA (TTM)
264.871
Gross margin (TTM)
96.56%
Net profit margin (TTM)
41.09%
Operating margin (TTM)
55.81%
Revenue per employee (TTM)
$11,450,000
Management effectiveness
Return on assets (TTM)
4.56%
Return on equity (TTM)
10.31%
Valuation
Price to earnings (TTM)
22.44
Price to revenue (TTM)
9.159
Price to book
2.32
Price to tangible book (TTM)
2.32
Price to free cash flow (TTM)
15.033
Free cash flow yield (TTM)
6.65%
Free cash flow per share (TTM)
471.22%
Dividend yield (TTM)
5.08%
Forward dividend yield
5.08%
Growth
Revenue change (TTM)
7.49%
Earnings per share change (TTM)
3.74%
3-year revenue growth (CAGR)
5.97%
10-year revenue growth (CAGR)
6.12%
3-year earnings per share growth (CAGR)
19.67%
10-year earnings per share growth (CAGR)
0.12%
10-year dividend per share growth (CAGR)
1.31%
What the Analysts think about NHI
Analyst ratings (Buy, Hold, Sell) for National Health Investors stock.
Bulls say / Bears say
National Health Investors (NHI) has demonstrated strong financial performance, with a net margin of 40.3%, indicating effective cost management and profitability. (markets.businessinsider.com)
Analysts have a positive outlook on NHI, with an average 12-month price target of $82.20, suggesting an 8.46% upside from the current price. (stockanalysis.com)
Bank of America initiated coverage on NHI with a 'Buy' rating and a $92.00 price target, indicating confidence in the company's growth prospects. (marketbeat.com)
Truist Financial downgraded NHI's price target from $78.00 to $72.00, maintaining a 'Hold' rating, reflecting concerns about the company's valuation. (defenseworld.net)
A Seeking Alpha analysis suggests that NHI's current valuation may not be attractive for conservative investors, indicating limited upside potential. (seekingalpha.com)
The healthcare sector faces policy uncertainties and budget cuts, which could impact companies like NHI that are dependent on regulatory approvals and funding. (reuters.com)
Data summarised monthly by Lightyear AI. Last updated on 8 Jun 2025.
NHI Financial Performance
Revenues and expenses
NHI Earnings Performance
Company profitability
NHI News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
Aug1
National Health Investors
Dividend·Payment
$0.90Per share
FAQs
What’s the current market cap for National Health Investors stock?
National Health Investors (NHI) has a market cap of $3.3B as of June 30, 2025.
What is the P/E ratio for National Health Investors stock?
The price to earnings (P/E) ratio for National Health Investors (NHI) stock is 22.44 as of June 30, 2025.
Does National Health Investors stock pay dividends?
Yes, the National Health Investors (NHI) stock pays dividends to shareholders. As of June 30, 2025, the dividend rate is $3.6 and the yield is 5.08%. National Health Investors has a payout ratio of 112.29% on a trailing twelve-month basis.
When is the next National Health Investors dividend payment date?
The next National Health Investors (NHI) dividend payment is scheduled for August 01, 2025.
What is the beta indicator for National Health Investors?
National Health Investors (NHI) has a beta rating of 0.81. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.